(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTAGONISTAS DE CGRP PARA TRATAMENTO DE CRISES DE ENXAQUECA

ArquivadaInvention PatentPCT · US2020014239

Application data

Number

112021011546

Type

Invention Patent

Filing

01/19/2020

Publication

08/31/2021

PCT

US2020014239

Progress at the INPI

  1. Filing01/19/20
  2. Publication08/31/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 01/19/2020 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 07/18/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.

US

See this company's full portfolio

Inventors

R. C. (pessoa física)

US

V. C. (pessoa física)

US

Technical data

Priority claims

US

62/794,665 · 01/20/2019

US

62/844,169 · 05/07/2019

US

62/893,206 · 08/29/2019

US

62/910,284 · 10/03/2019

US

62/959,088 · 01/09/2020

Abstract

ANTAGONISTAS DE CGRP PARA TRATAMENTO DE CRISES DE ENXAQUECA.São descritos métodos de tratamento de crise de enxaqueca em pacientes que usam antagonistas de CGRP contra as crises. Também são descritos métodos para o tratamento profilático da enxaqueca.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

07/18/2023

RPI 2741

Arquivamento - Art. 33 da LPI

#11.1

05/02/2023

RPI 2730

Notificação de entrada na fase nacional - PCT

#1.3

08/31/2021

RPI 2643

Alteração de dados cadastrais

#1.1

06/22/2021

RPI 2633

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.